nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Methotrexate—multiple sclerosis	0.0432	0.267	CbGbCtD
Dipyridamole—ABCB1—Methylprednisolone—multiple sclerosis	0.0275	0.17	CbGbCtD
Dipyridamole—ABCB1—Mitoxantrone—multiple sclerosis	0.0201	0.124	CbGbCtD
Dipyridamole—PDE6H—pineal body—multiple sclerosis	0.019	0.075	CbGeAlD
Dipyridamole—ABCB1—Betamethasone—multiple sclerosis	0.0179	0.111	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—multiple sclerosis	0.0177	0.109	CbGbCtD
Dipyridamole—ABCB1—Prednisone—multiple sclerosis	0.0167	0.103	CbGbCtD
Dipyridamole—PDE8B—leg—multiple sclerosis	0.0158	0.0622	CbGeAlD
Dipyridamole—ABCB1—Dexamethasone—multiple sclerosis	0.0104	0.0644	CbGbCtD
Dipyridamole—PDE6A—retina—multiple sclerosis	0.0102	0.0404	CbGeAlD
Dipyridamole—PDE6C—retina—multiple sclerosis	0.0097	0.0383	CbGeAlD
Dipyridamole—ABCB1—Methotrexate—multiple sclerosis	0.00837	0.0517	CbGbCtD
Dipyridamole—PDE6B—retina—multiple sclerosis	0.00615	0.0243	CbGeAlD
Dipyridamole—PDE6H—retina—multiple sclerosis	0.00572	0.0226	CbGeAlD
Dipyridamole—PDE6G—retina—multiple sclerosis	0.0055	0.0217	CbGeAlD
Dipyridamole—PDE1C—midbrain—multiple sclerosis	0.00474	0.0187	CbGeAlD
Dipyridamole—PDE6B—medulla oblongata—multiple sclerosis	0.00444	0.0175	CbGeAlD
Dipyridamole—PDE6D—midbrain—multiple sclerosis	0.00413	0.0163	CbGeAlD
Dipyridamole—PDE6B—midbrain—multiple sclerosis	0.00406	0.016	CbGeAlD
Dipyridamole—PDE6B—spinal cord—multiple sclerosis	0.00396	0.0156	CbGeAlD
Dipyridamole—PDE1C—nervous system—multiple sclerosis	0.0039	0.0154	CbGeAlD
Dipyridamole—PDE1C—central nervous system—multiple sclerosis	0.00375	0.0148	CbGeAlD
Dipyridamole—PDE1C—cerebellum—multiple sclerosis	0.00367	0.0145	CbGeAlD
Dipyridamole—PDE6B—nervous system—multiple sclerosis	0.00334	0.0132	CbGeAlD
Dipyridamole—PRUNE—cerebellum—multiple sclerosis	0.00331	0.013	CbGeAlD
Dipyridamole—PDE6B—central nervous system—multiple sclerosis	0.00321	0.0127	CbGeAlD
Dipyridamole—PDE1A—brainstem—multiple sclerosis	0.0032	0.0126	CbGeAlD
Dipyridamole—PDE6D—cerebellum—multiple sclerosis	0.00319	0.0126	CbGeAlD
Dipyridamole—PDE6B—cerebellum—multiple sclerosis	0.00314	0.0124	CbGeAlD
Dipyridamole—PDE6H—nervous system—multiple sclerosis	0.0031	0.0122	CbGeAlD
Dipyridamole—PDE6H—central nervous system—multiple sclerosis	0.00299	0.0118	CbGeAlD
Dipyridamole—PDE1C—brain—multiple sclerosis	0.00298	0.0118	CbGeAlD
Dipyridamole—PDE7A—nervous system—multiple sclerosis	0.00277	0.0109	CbGeAlD
Dipyridamole—PDE2A—medulla oblongata—multiple sclerosis	0.00269	0.0106	CbGeAlD
Dipyridamole—PRUNE—brain—multiple sclerosis	0.00269	0.0106	CbGeAlD
Dipyridamole—PDE7A—central nervous system—multiple sclerosis	0.00266	0.0105	CbGeAlD
Dipyridamole—PDE6D—brain—multiple sclerosis	0.00259	0.0102	CbGeAlD
Dipyridamole—PDE6B—brain—multiple sclerosis	0.00255	0.0101	CbGeAlD
Dipyridamole—PDE2A—midbrain—multiple sclerosis	0.00245	0.00969	CbGeAlD
Dipyridamole—PDE7B—nervous system—multiple sclerosis	0.00242	0.00954	CbGeAlD
Dipyridamole—PDE2A—spinal cord—multiple sclerosis	0.0024	0.00945	CbGeAlD
Dipyridamole—PDE6H—brain—multiple sclerosis	0.00237	0.00936	CbGeAlD
Dipyridamole—PDE11A—brain—multiple sclerosis	0.00237	0.00936	CbGeAlD
Dipyridamole—PDE8B—midbrain—multiple sclerosis	0.00234	0.00924	CbGeAlD
Dipyridamole—PDE7B—central nervous system—multiple sclerosis	0.00233	0.00919	CbGeAlD
Dipyridamole—PDE8A—medulla oblongata—multiple sclerosis	0.0023	0.0091	CbGeAlD
Dipyridamole—PDE1A—medulla oblongata—multiple sclerosis	0.00223	0.0088	CbGeAlD
Dipyridamole—PDE5A—retina—multiple sclerosis	0.00217	0.00858	CbGeAlD
Dipyridamole—PDE7A—brain—multiple sclerosis	0.00211	0.00835	CbGeAlD
Dipyridamole—PDE8A—midbrain—multiple sclerosis	0.00211	0.00831	CbGeAlD
Dipyridamole—PDE8A—spinal cord—multiple sclerosis	0.00206	0.00811	CbGeAlD
Dipyridamole—PDE1A—midbrain—multiple sclerosis	0.00204	0.00805	CbGeAlD
Dipyridamole—PDE2A—nervous system—multiple sclerosis	0.00202	0.00796	CbGeAlD
Dipyridamole—PDE10A—nervous system—multiple sclerosis	0.00202	0.00796	CbGeAlD
Dipyridamole—PDE1B—nervous system—multiple sclerosis	0.002	0.00789	CbGeAlD
Dipyridamole—PDE1A—spinal cord—multiple sclerosis	0.00199	0.00785	CbGeAlD
Dipyridamole—ABCC5—retina—multiple sclerosis	0.00199	0.00785	CbGeAlD
Dipyridamole—PDE10A—central nervous system—multiple sclerosis	0.00194	0.00767	CbGeAlD
Dipyridamole—PDE2A—central nervous system—multiple sclerosis	0.00194	0.00767	CbGeAlD
Dipyridamole—PDE1B—central nervous system—multiple sclerosis	0.00193	0.0076	CbGeAlD
Dipyridamole—PDE8B—nervous system—multiple sclerosis	0.00193	0.0076	CbGeAlD
Dipyridamole—PDE2A—cerebellum—multiple sclerosis	0.0019	0.0075	CbGeAlD
Dipyridamole—PDE10A—cerebellum—multiple sclerosis	0.0019	0.0075	CbGeAlD
Dipyridamole—PDE1B—cerebellum—multiple sclerosis	0.00188	0.00743	CbGeAlD
Dipyridamole—PDE8B—central nervous system—multiple sclerosis	0.00185	0.00732	CbGeAlD
Dipyridamole—PDE7B—brain—multiple sclerosis	0.00185	0.00729	CbGeAlD
Dipyridamole—PDE8B—cerebellum—multiple sclerosis	0.00181	0.00715	CbGeAlD
Dipyridamole—PDE3B—cerebellum—multiple sclerosis	0.00177	0.00698	CbGeAlD
Dipyridamole—PDE1A—nervous system—multiple sclerosis	0.00168	0.00661	CbGeAlD
Dipyridamole—PDE8A—cerebellum—multiple sclerosis	0.00163	0.00643	CbGeAlD
Dipyridamole—PDE1A—central nervous system—multiple sclerosis	0.00161	0.00637	CbGeAlD
Dipyridamole—PDE1A—cerebellum—multiple sclerosis	0.00158	0.00622	CbGeAlD
Dipyridamole—PDE2A—brain—multiple sclerosis	0.00154	0.00609	CbGeAlD
Dipyridamole—PDE10A—brain—multiple sclerosis	0.00154	0.00609	CbGeAlD
Dipyridamole—PDE1B—brain—multiple sclerosis	0.00153	0.00603	CbGeAlD
Dipyridamole—PDE8B—brain—multiple sclerosis	0.00147	0.00581	CbGeAlD
Dipyridamole—ABCC5—medulla oblongata—multiple sclerosis	0.00144	0.00567	CbGeAlD
Dipyridamole—PDE3B—brain—multiple sclerosis	0.00144	0.00567	CbGeAlD
Dipyridamole—ADA—nervous system—multiple sclerosis	0.00143	0.00562	CbGeAlD
Dipyridamole—ADA—central nervous system—multiple sclerosis	0.00137	0.00542	CbGeAlD
Dipyridamole—PDE8A—brain—multiple sclerosis	0.00132	0.00522	CbGeAlD
Dipyridamole—ABCC5—midbrain—multiple sclerosis	0.00131	0.00518	CbGeAlD
Dipyridamole—PDE4A—cerebellum—multiple sclerosis	0.00131	0.00516	CbGeAlD
Dipyridamole—PDE1A—brain—multiple sclerosis	0.00128	0.00506	CbGeAlD
Dipyridamole—PDE5A—nervous system—multiple sclerosis	0.00118	0.00466	CbGeAlD
Dipyridamole—PDE5A—central nervous system—multiple sclerosis	0.00114	0.00449	CbGeAlD
Dipyridamole—PDE5A—cerebellum—multiple sclerosis	0.00111	0.00439	CbGeAlD
Dipyridamole—ADA—brain—multiple sclerosis	0.00109	0.0043	CbGeAlD
Dipyridamole—PDE3A—cerebellum—multiple sclerosis	0.00108	0.00427	CbGeAlD
Dipyridamole—PDE4A—brain—multiple sclerosis	0.00106	0.00419	CbGeAlD
Dipyridamole—ABCC5—cerebellum—multiple sclerosis	0.00102	0.00401	CbGeAlD
Dipyridamole—SLC29A1—nervous system—multiple sclerosis	0.000992	0.00391	CbGeAlD
Dipyridamole—SLC29A1—central nervous system—multiple sclerosis	0.000955	0.00377	CbGeAlD
Dipyridamole—SLC29A1—cerebellum—multiple sclerosis	0.000933	0.00368	CbGeAlD
Dipyridamole—PDE5A—brain—multiple sclerosis	0.000903	0.00356	CbGeAlD
Dipyridamole—PDE3A—brain—multiple sclerosis	0.000878	0.00347	CbGeAlD
Dipyridamole—ABCC5—brain—multiple sclerosis	0.000826	0.00326	CbGeAlD
Dipyridamole—SLC29A1—brain—multiple sclerosis	0.000758	0.00299	CbGeAlD
Dipyridamole—ABCC4—nervous system—multiple sclerosis	0.000749	0.00295	CbGeAlD
Dipyridamole—ABCC4—central nervous system—multiple sclerosis	0.000721	0.00284	CbGeAlD
Dipyridamole—ABCC4—brain—multiple sclerosis	0.000572	0.00226	CbGeAlD
Dipyridamole—ABCB1—retina—multiple sclerosis	0.00048	0.00189	CbGeAlD
Dipyridamole—Myalgia—Triamcinolone—multiple sclerosis	0.000362	0.00126	CcSEcCtD
Dipyridamole—Vomiting—Azathioprine—multiple sclerosis	0.000362	0.00126	CcSEcCtD
Dipyridamole—Myalgia—Methylprednisolone—multiple sclerosis	0.000361	0.00126	CcSEcCtD
Dipyridamole—Arthralgia—Methylprednisolone—multiple sclerosis	0.000361	0.00126	CcSEcCtD
Dipyridamole—Anxiety—Methylprednisolone—multiple sclerosis	0.00036	0.00125	CcSEcCtD
Dipyridamole—Rash—Azathioprine—multiple sclerosis	0.000359	0.00125	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000359	0.00125	CcSEcCtD
Dipyridamole—Dermatitis—Azathioprine—multiple sclerosis	0.000358	0.00125	CcSEcCtD
Dipyridamole—Flushing—Prednisone—multiple sclerosis	0.000358	0.00124	CcSEcCtD
Dipyridamole—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000358	0.00124	CcSEcCtD
Dipyridamole—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000358	0.00124	CcSEcCtD
Dipyridamole—Discomfort—Triamcinolone—multiple sclerosis	0.000358	0.00124	CcSEcCtD
Dipyridamole—Discomfort—Methylprednisolone—multiple sclerosis	0.000357	0.00124	CcSEcCtD
Dipyridamole—Headache—Azathioprine—multiple sclerosis	0.000356	0.00124	CcSEcCtD
Dipyridamole—Dry mouth—Triamcinolone—multiple sclerosis	0.000354	0.00123	CcSEcCtD
Dipyridamole—Angioedema—Dexamethasone—multiple sclerosis	0.000352	0.00123	CcSEcCtD
Dipyridamole—Angioedema—Betamethasone—multiple sclerosis	0.000352	0.00123	CcSEcCtD
Dipyridamole—Angiopathy—Prednisone—multiple sclerosis	0.00035	0.00122	CcSEcCtD
Dipyridamole—Immune system disorder—Prednisone—multiple sclerosis	0.000349	0.00121	CcSEcCtD
Dipyridamole—Malaise—Betamethasone—multiple sclerosis	0.000348	0.00121	CcSEcCtD
Dipyridamole—Malaise—Dexamethasone—multiple sclerosis	0.000348	0.00121	CcSEcCtD
Dipyridamole—Oedema—Triamcinolone—multiple sclerosis	0.000347	0.00121	CcSEcCtD
Dipyridamole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000347	0.00121	CcSEcCtD
Dipyridamole—ABCB1—medulla oblongata—multiple sclerosis	0.000347	0.00137	CbGeAlD
Dipyridamole—Vertigo—Betamethasone—multiple sclerosis	0.000347	0.0012	CcSEcCtD
Dipyridamole—Vertigo—Dexamethasone—multiple sclerosis	0.000347	0.0012	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000346	0.0012	CcSEcCtD
Dipyridamole—Syncope—Dexamethasone—multiple sclerosis	0.000346	0.0012	CcSEcCtD
Dipyridamole—Syncope—Betamethasone—multiple sclerosis	0.000346	0.0012	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—multiple sclerosis	0.000345	0.0012	CcSEcCtD
Dipyridamole—Shock—Triamcinolone—multiple sclerosis	0.000341	0.00119	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—multiple sclerosis	0.000341	0.00119	CcSEcCtD
Dipyridamole—Shock—Methylprednisolone—multiple sclerosis	0.000341	0.00118	CcSEcCtD
Dipyridamole—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—multiple sclerosis	0.000339	0.00118	CcSEcCtD
Dipyridamole—Nausea—Azathioprine—multiple sclerosis	0.000338	0.00117	CcSEcCtD
Dipyridamole—Tachycardia—Methylprednisolone—multiple sclerosis	0.000338	0.00117	CcSEcCtD
Dipyridamole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000336	0.00117	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000335	0.00117	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000335	0.00116	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—multiple sclerosis	0.000334	0.00116	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—multiple sclerosis	0.000334	0.00116	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—multiple sclerosis	0.000333	0.00116	CcSEcCtD
Dipyridamole—Asthenia—Mitoxantrone—multiple sclerosis	0.00033	0.00115	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—multiple sclerosis	0.000328	0.00114	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—multiple sclerosis	0.000328	0.00114	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—multiple sclerosis	0.000327	0.00114	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—multiple sclerosis	0.000327	0.00114	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—multiple sclerosis	0.000324	0.00113	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—multiple sclerosis	0.000324	0.00113	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—multiple sclerosis	0.000324	0.00113	CcSEcCtD
Dipyridamole—Hypotension—Methylprednisolone—multiple sclerosis	0.000323	0.00112	CcSEcCtD
Dipyridamole—Pain—Prednisolone—multiple sclerosis	0.000323	0.00112	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—multiple sclerosis	0.000322	0.00112	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—multiple sclerosis	0.000322	0.00112	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—multiple sclerosis	0.00032	0.00111	CcSEcCtD
Dipyridamole—ABCB1—midbrain—multiple sclerosis	0.000317	0.00125	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000316	0.0011	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000315	0.0011	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000315	0.00109	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—multiple sclerosis	0.000315	0.00109	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—multiple sclerosis	0.000315	0.00109	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000315	0.00109	CcSEcCtD
Dipyridamole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000315	0.00109	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000312	0.00108	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000312	0.00108	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000311	0.00108	CcSEcCtD
Dipyridamole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000311	0.00108	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—multiple sclerosis	0.00031	0.00108	CcSEcCtD
Dipyridamole—Shock—Betamethasone—multiple sclerosis	0.00031	0.00108	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—multiple sclerosis	0.00031	0.00108	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000309	0.00108	CcSEcCtD
Dipyridamole—ABCB1—spinal cord—multiple sclerosis	0.000309	0.00122	CbGeAlD
Dipyridamole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000309	0.00107	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000309	0.00107	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000308	0.00107	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000308	0.00107	CcSEcCtD
Dipyridamole—Tachycardia—Betamethasone—multiple sclerosis	0.000307	0.00107	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—multiple sclerosis	0.000307	0.00107	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—multiple sclerosis	0.000307	0.00107	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000305	0.00106	CcSEcCtD
Dipyridamole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000305	0.00106	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000304	0.00106	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000304	0.00106	CcSEcCtD
Dipyridamole—Malaise—Prednisone—multiple sclerosis	0.000303	0.00105	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—multiple sclerosis	0.000302	0.00105	CcSEcCtD
Dipyridamole—Syncope—Prednisone—multiple sclerosis	0.000301	0.00105	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—multiple sclerosis	0.000301	0.00105	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—multiple sclerosis	0.0003	0.00104	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—multiple sclerosis	0.000299	0.00104	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—multiple sclerosis	0.000299	0.00104	CcSEcCtD
Dipyridamole—Fatigue—Methylprednisolone—multiple sclerosis	0.000298	0.00104	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—multiple sclerosis	0.000297	0.00103	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—multiple sclerosis	0.000295	0.00103	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—multiple sclerosis	0.000294	0.00102	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—multiple sclerosis	0.000294	0.00102	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—multiple sclerosis	0.000293	0.00102	CcSEcCtD
Dipyridamole—Vomiting—Mitoxantrone—multiple sclerosis	0.000292	0.00102	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—multiple sclerosis	0.000291	0.00101	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—multiple sclerosis	0.000291	0.00101	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000291	0.00101	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—multiple sclerosis	0.00029	0.00101	CcSEcCtD
Dipyridamole—Rash—Mitoxantrone—multiple sclerosis	0.00029	0.00101	CcSEcCtD
Dipyridamole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00029	0.00101	CcSEcCtD
Dipyridamole—Chills—Methotrexate—multiple sclerosis	0.000289	0.00101	CcSEcCtD
Dipyridamole—Headache—Mitoxantrone—multiple sclerosis	0.000288	0.001	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000287	0.000997	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000287	0.000997	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—multiple sclerosis	0.000286	0.000994	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—multiple sclerosis	0.000286	0.000994	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000286	0.000994	CcSEcCtD
Dipyridamole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000285	0.000992	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—multiple sclerosis	0.000285	0.000991	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—multiple sclerosis	0.000285	0.000991	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000284	0.000987	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000283	0.000984	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000283	0.000983	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—multiple sclerosis	0.000283	0.000983	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—multiple sclerosis	0.000283	0.000982	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000278	0.000966	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—multiple sclerosis	0.000277	0.000963	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000277	0.000963	CcSEcCtD
Dipyridamole—Urticaria—Triamcinolone—multiple sclerosis	0.000276	0.000958	CcSEcCtD
Dipyridamole—Urticaria—Methylprednisolone—multiple sclerosis	0.000275	0.000956	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—multiple sclerosis	0.000275	0.000956	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000274	0.000953	CcSEcCtD
Dipyridamole—Oedema—Prednisone—multiple sclerosis	0.000274	0.000953	CcSEcCtD
Dipyridamole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000274	0.000951	CcSEcCtD
Dipyridamole—Nausea—Mitoxantrone—multiple sclerosis	0.000273	0.00095	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000272	0.000945	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000272	0.000945	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—multiple sclerosis	0.000272	0.000944	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—multiple sclerosis	0.000271	0.000943	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—multiple sclerosis	0.000271	0.000943	CcSEcCtD
Dipyridamole—Shock—Prednisone—multiple sclerosis	0.00027	0.000938	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—multiple sclerosis	0.000269	0.000936	CcSEcCtD
Dipyridamole—Pain—Betamethasone—multiple sclerosis	0.000269	0.000936	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—multiple sclerosis	0.000269	0.000935	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—multiple sclerosis	0.000268	0.00093	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—multiple sclerosis	0.000266	0.000926	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—multiple sclerosis	0.000265	0.000921	CcSEcCtD
Dipyridamole—ABCB1—nervous system—multiple sclerosis	0.000261	0.00103	CbGeAlD
Dipyridamole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00026	0.000905	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—multiple sclerosis	0.000259	0.000902	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000259	0.000902	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000259	0.000902	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000257	0.000895	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000257	0.000895	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000256	0.000889	CcSEcCtD
Dipyridamole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000255	0.000887	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—multiple sclerosis	0.000253	0.00088	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—multiple sclerosis	0.000252	0.000877	CcSEcCtD
Dipyridamole—ABCB1—central nervous system—multiple sclerosis	0.000251	0.00099	CbGeAlD
Dipyridamole—Urticaria—Betamethasone—multiple sclerosis	0.00025	0.000869	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—multiple sclerosis	0.00025	0.000869	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00025	0.000868	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—multiple sclerosis	0.000249	0.000867	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—multiple sclerosis	0.000249	0.000865	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—multiple sclerosis	0.000249	0.000865	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000249	0.000865	CcSEcCtD
Dipyridamole—Asthenia—Methylprednisolone—multiple sclerosis	0.000248	0.000863	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—multiple sclerosis	0.000246	0.000856	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—multiple sclerosis	0.000245	0.000853	CcSEcCtD
Dipyridamole—ABCB1—cerebellum—multiple sclerosis	0.000245	0.000968	CbGeAlD
Dipyridamole—Cough—Methotrexate—multiple sclerosis	0.000245	0.000852	CcSEcCtD
Dipyridamole—Pruritus—Methylprednisolone—multiple sclerosis	0.000245	0.000851	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—multiple sclerosis	0.000243	0.000846	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—multiple sclerosis	0.000241	0.000839	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—multiple sclerosis	0.000239	0.000831	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—multiple sclerosis	0.000239	0.000831	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—multiple sclerosis	0.000239	0.000831	CcSEcCtD
Dipyridamole—Rash—Prednisolone—multiple sclerosis	0.000238	0.000827	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—multiple sclerosis	0.000238	0.000826	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000237	0.000825	CcSEcCtD
Dipyridamole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000237	0.000823	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—multiple sclerosis	0.000236	0.000822	CcSEcCtD
Dipyridamole—Headache—Prednisolone—multiple sclerosis	0.000236	0.000822	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—multiple sclerosis	0.000236	0.000821	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—multiple sclerosis	0.000229	0.000798	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000229	0.000796	CcSEcCtD
Dipyridamole—Dizziness—Methylprednisolone—multiple sclerosis	0.000229	0.000796	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—multiple sclerosis	0.000226	0.000785	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—multiple sclerosis	0.000226	0.000785	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—multiple sclerosis	0.000226	0.000785	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—multiple sclerosis	0.000225	0.000781	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000224	0.00078	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000224	0.000779	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—multiple sclerosis	0.000224	0.000779	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—multiple sclerosis	0.000223	0.000774	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—multiple sclerosis	0.000223	0.000774	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—multiple sclerosis	0.000223	0.000774	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000221	0.00077	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—multiple sclerosis	0.000221	0.000767	CcSEcCtD
Dipyridamole—Vomiting—Methylprednisolone—multiple sclerosis	0.00022	0.000765	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—multiple sclerosis	0.000219	0.00076	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—multiple sclerosis	0.000219	0.00076	CcSEcCtD
Dipyridamole—Rash—Methylprednisolone—multiple sclerosis	0.000218	0.000759	CcSEcCtD
Dipyridamole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000218	0.000758	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—multiple sclerosis	0.000218	0.000757	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—multiple sclerosis	0.000217	0.000756	CcSEcCtD
Dipyridamole—Headache—Methylprednisolone—multiple sclerosis	0.000217	0.000754	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—multiple sclerosis	0.000217	0.000753	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000215	0.000749	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—multiple sclerosis	0.000215	0.000749	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—multiple sclerosis	0.000214	0.000744	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000209	0.000726	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—multiple sclerosis	0.000208	0.000724	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—multiple sclerosis	0.000208	0.000724	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—multiple sclerosis	0.000206	0.000716	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—multiple sclerosis	0.000206	0.000715	CcSEcCtD
Dipyridamole—Nausea—Methylprednisolone—multiple sclerosis	0.000206	0.000715	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—multiple sclerosis	0.000204	0.00071	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—multiple sclerosis	0.000204	0.000708	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—multiple sclerosis	0.000202	0.000702	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—multiple sclerosis	0.000202	0.000701	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—multiple sclerosis	0.0002	0.000696	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—multiple sclerosis	0.0002	0.000696	CcSEcCtD
Dipyridamole—ABCB1—brain—multiple sclerosis	0.000199	0.000786	CbGeAlD
Dipyridamole—Rash—Betamethasone—multiple sclerosis	0.000198	0.00069	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—multiple sclerosis	0.000198	0.00069	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—multiple sclerosis	0.000198	0.000689	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—multiple sclerosis	0.000198	0.000689	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000198	0.000688	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—multiple sclerosis	0.000198	0.000687	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—multiple sclerosis	0.000197	0.000686	CcSEcCtD
Dipyridamole—Headache—Betamethasone—multiple sclerosis	0.000197	0.000686	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—multiple sclerosis	0.000197	0.000684	CcSEcCtD
Dipyridamole—Pain—Methotrexate—multiple sclerosis	0.000196	0.000681	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—multiple sclerosis	0.000194	0.000674	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—multiple sclerosis	0.000189	0.000656	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—multiple sclerosis	0.000188	0.000652	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000187	0.000651	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—multiple sclerosis	0.000187	0.00065	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—multiple sclerosis	0.000187	0.00065	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—multiple sclerosis	0.000182	0.000633	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—multiple sclerosis	0.000181	0.00063	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—multiple sclerosis	0.000181	0.00063	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—multiple sclerosis	0.000174	0.000606	CcSEcCtD
Dipyridamole—Rash—Prednisone—multiple sclerosis	0.000173	0.000601	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—multiple sclerosis	0.000173	0.0006	CcSEcCtD
Dipyridamole—Headache—Prednisone—multiple sclerosis	0.000172	0.000597	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—multiple sclerosis	0.000169	0.000587	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—multiple sclerosis	0.000164	0.000571	CcSEcCtD
Dipyridamole—Nausea—Prednisone—multiple sclerosis	0.000163	0.000566	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—multiple sclerosis	0.000162	0.000563	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—multiple sclerosis	0.000157	0.000545	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—multiple sclerosis	0.000152	0.000527	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—multiple sclerosis	0.000146	0.000506	CcSEcCtD
Dipyridamole—Rash—Methotrexate—multiple sclerosis	0.000144	0.000502	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—multiple sclerosis	0.000144	0.000502	CcSEcCtD
Dipyridamole—Headache—Methotrexate—multiple sclerosis	0.000144	0.000499	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—multiple sclerosis	0.000136	0.000473	CcSEcCtD
Dipyridamole—PDE10A—Signaling Pathways—TYK2—multiple sclerosis	3.82e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—multiple sclerosis	3.81e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—TYK2—multiple sclerosis	3.81e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CD86—multiple sclerosis	3.75e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TGFB1—multiple sclerosis	3.7e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL5—multiple sclerosis	3.7e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MYC—multiple sclerosis	3.69e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—POMC—multiple sclerosis	3.68e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ICAM1—multiple sclerosis	3.68e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TGFB1—multiple sclerosis	3.68e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SPP1—multiple sclerosis	3.66e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CD86—multiple sclerosis	3.65e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MYC—multiple sclerosis	3.64e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—MAPK1—multiple sclerosis	3.63e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—multiple sclerosis	3.63e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—multiple sclerosis	3.63e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—APOE—multiple sclerosis	3.62e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—STAT3—multiple sclerosis	3.62e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—STAT3—multiple sclerosis	3.62e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MAPK1—multiple sclerosis	3.61e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CCL2—multiple sclerosis	3.61e-05	0.000121	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2—multiple sclerosis	3.6e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL5—multiple sclerosis	3.6e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL10—multiple sclerosis	3.59e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2—multiple sclerosis	3.59e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—TYK2—multiple sclerosis	3.58e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD80—multiple sclerosis	3.58e-05	0.00012	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD80—multiple sclerosis	3.58e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—MAPK1—multiple sclerosis	3.57e-05	0.00012	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—multiple sclerosis	3.57e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2—multiple sclerosis	3.56e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2—multiple sclerosis	3.56e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MAPK1—multiple sclerosis	3.56e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCR5—multiple sclerosis	3.56e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—multiple sclerosis	3.54e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—multiple sclerosis	3.54e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD80—multiple sclerosis	3.54e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—STAT3—multiple sclerosis	3.53e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2RA—multiple sclerosis	3.5e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2—multiple sclerosis	3.49e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2—multiple sclerosis	3.48e-05	0.000117	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.48e-05	0.000117	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.48e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD86—multiple sclerosis	3.43e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SPP1—multiple sclerosis	3.42e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL5—multiple sclerosis	3.38e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—multiple sclerosis	3.37e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—multiple sclerosis	3.37e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MYC—multiple sclerosis	3.36e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MYC—multiple sclerosis	3.36e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—multiple sclerosis	3.35e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—multiple sclerosis	3.35e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	3.33e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SPP1—multiple sclerosis	3.33e-05	0.000112	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOE—multiple sclerosis	3.31e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—multiple sclerosis	3.3e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MAPK1—multiple sclerosis	3.29e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MAPK1—multiple sclerosis	3.29e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—multiple sclerosis	3.29e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	3.28e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—multiple sclerosis	3.28e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MYC—multiple sclerosis	3.28e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—TYK2—multiple sclerosis	3.27e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD80—multiple sclerosis	3.27e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TYK2—multiple sclerosis	3.27e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—MAPK1—multiple sclerosis	3.27e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—multiple sclerosis	3.27e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—multiple sclerosis	3.26e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	3.26e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR5—multiple sclerosis	3.24e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOE—multiple sclerosis	3.24e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—STAT3—multiple sclerosis	3.22e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MAPK1—multiple sclerosis	3.2e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2RA—multiple sclerosis	3.19e-05	0.000107	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPC5—multiple sclerosis	3.18e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—multiple sclerosis	3.18e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—multiple sclerosis	3.17e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—multiple sclerosis	3.16e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD86—multiple sclerosis	3.14e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SPP1—multiple sclerosis	3.13e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—multiple sclerosis	3.13e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL5—multiple sclerosis	3.09e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—multiple sclerosis	3.08e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—multiple sclerosis	3.06e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR5—multiple sclerosis	3.05e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOE—multiple sclerosis	3.03e-05	0.000102	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TYK2—multiple sclerosis	3.02e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TYK2—multiple sclerosis	3.02e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—multiple sclerosis	3.01e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2RA—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—STAT3—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—STAT3—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MYC—multiple sclerosis	3e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TYK2—multiple sclerosis	2.99e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—multiple sclerosis	2.99e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—multiple sclerosis	2.98e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—multiple sclerosis	2.97e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—multiple sclerosis	2.97e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—multiple sclerosis	2.96e-05	9.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOE—multiple sclerosis	2.95e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MAPK1—multiple sclerosis	2.93e-05	9.86e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CD80—multiple sclerosis	2.93e-05	9.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SPP1—multiple sclerosis	2.86e-05	9.64e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—POMC—multiple sclerosis	2.85e-05	9.58e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—multiple sclerosis	2.81e-05	9.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—multiple sclerosis	2.8e-05	9.43e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MYC—multiple sclerosis	2.79e-05	9.37e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MYC—multiple sclerosis	2.79e-05	9.37e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR5—multiple sclerosis	2.79e-05	9.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—POMC—multiple sclerosis	2.78e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—STAT3—multiple sclerosis	2.78e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—multiple sclerosis	2.78e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—multiple sclerosis	2.78e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—multiple sclerosis	2.77e-05	9.33e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOE—multiple sclerosis	2.77e-05	9.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TYK2—multiple sclerosis	2.76e-05	9.29e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—MAPK1—multiple sclerosis	2.75e-05	9.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—multiple sclerosis	2.75e-05	9.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2RA—multiple sclerosis	2.74e-05	9.24e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—STAT3—multiple sclerosis	2.74e-05	9.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CD80—multiple sclerosis	2.74e-05	9.22e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—multiple sclerosis	2.73e-05	9.2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—multiple sclerosis	2.73e-05	9.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—multiple sclerosis	2.73e-05	9.19e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—multiple sclerosis	2.73e-05	9.19e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MAPK1—multiple sclerosis	2.73e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MAPK1—multiple sclerosis	2.73e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—multiple sclerosis	2.72e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—multiple sclerosis	2.72e-05	9.16e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL2—multiple sclerosis	2.72e-05	9.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—multiple sclerosis	2.71e-05	9.1e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—STAT3—multiple sclerosis	2.67e-05	8.99e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CD80—multiple sclerosis	2.66e-05	8.97e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—MAPK1—multiple sclerosis	2.66e-05	8.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RRM1—multiple sclerosis	2.64e-05	8.87e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—POMC—multiple sclerosis	2.6e-05	8.76e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—multiple sclerosis	2.59e-05	8.73e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MYC—multiple sclerosis	2.58e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—multiple sclerosis	2.58e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MYC—multiple sclerosis	2.55e-05	8.57e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	2.55e-05	8.57e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—multiple sclerosis	2.54e-05	8.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—multiple sclerosis	2.53e-05	8.53e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—POMC—multiple sclerosis	2.53e-05	8.52e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—multiple sclerosis	2.53e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—multiple sclerosis	2.53e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MAPK1—multiple sclerosis	2.53e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—multiple sclerosis	2.51e-05	8.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD80—multiple sclerosis	2.5e-05	8.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—multiple sclerosis	2.5e-05	8.41e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—multiple sclerosis	2.5e-05	8.41e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MAPK1—multiple sclerosis	2.49e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	2.49e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—multiple sclerosis	2.49e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—multiple sclerosis	2.48e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—multiple sclerosis	2.48e-05	8.34e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—multiple sclerosis	2.48e-05	8.34e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TYK2—multiple sclerosis	2.47e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—multiple sclerosis	2.46e-05	8.29e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.43e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MAPK1—multiple sclerosis	2.43e-05	8.17e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.43e-05	8.16e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—MAPK1—multiple sclerosis	2.42e-05	8.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—multiple sclerosis	2.38e-05	8.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.38e-05	8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—multiple sclerosis	2.33e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	2.31e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD80—multiple sclerosis	2.29e-05	7.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—multiple sclerosis	2.29e-05	7.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.28e-05	7.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.26e-05	7.62e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—multiple sclerosis	2.25e-05	7.58e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TYK2—multiple sclerosis	2.25e-05	7.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—multiple sclerosis	2.18e-05	7.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—multiple sclerosis	2.13e-05	7.17e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TYK2—multiple sclerosis	2.11e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—multiple sclerosis	2.11e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—multiple sclerosis	2.11e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—multiple sclerosis	2.09e-05	7.05e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—multiple sclerosis	2.09e-05	7.05e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—multiple sclerosis	2.09e-05	7.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.08e-05	7.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MAPK1—multiple sclerosis	2.08e-05	7.01e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—multiple sclerosis	2.05e-05	6.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—multiple sclerosis	2.04e-05	6.88e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—multiple sclerosis	1.96e-05	6.61e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—multiple sclerosis	1.96e-05	6.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—multiple sclerosis	1.96e-05	6.6e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—multiple sclerosis	1.96e-05	6.6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—multiple sclerosis	1.94e-05	6.54e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—multiple sclerosis	1.94e-05	6.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TYK2—multiple sclerosis	1.93e-05	6.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—multiple sclerosis	1.93e-05	6.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—multiple sclerosis	1.92e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAPK1—multiple sclerosis	1.92e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAPK1—multiple sclerosis	1.92e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—multiple sclerosis	1.92e-05	6.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	1.91e-05	6.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK1—multiple sclerosis	1.9e-05	6.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—multiple sclerosis	1.87e-05	6.3e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—multiple sclerosis	1.87e-05	6.28e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—multiple sclerosis	1.86e-05	6.27e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	1.82e-05	6.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—multiple sclerosis	1.8e-05	6.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—multiple sclerosis	1.79e-05	6.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—multiple sclerosis	1.77e-05	5.96e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—multiple sclerosis	1.76e-05	5.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAPK1—multiple sclerosis	1.76e-05	5.92e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—multiple sclerosis	1.75e-05	5.89e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—multiple sclerosis	1.73e-05	5.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—multiple sclerosis	1.67e-05	5.6e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	1.62e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—multiple sclerosis	1.61e-05	5.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—multiple sclerosis	1.61e-05	5.41e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—multiple sclerosis	1.6e-05	5.39e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—multiple sclerosis	1.6e-05	5.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—multiple sclerosis	1.6e-05	5.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—multiple sclerosis	1.57e-05	5.3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK1—multiple sclerosis	1.57e-05	5.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—multiple sclerosis	1.52e-05	5.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.52e-05	5.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—multiple sclerosis	1.51e-05	5.09e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—multiple sclerosis	1.5e-05	5.06e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	1.5e-05	5.05e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—multiple sclerosis	1.48e-05	4.98e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—multiple sclerosis	1.48e-05	4.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—multiple sclerosis	1.48e-05	4.97e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	1.47e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—multiple sclerosis	1.46e-05	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—multiple sclerosis	1.46e-05	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—multiple sclerosis	1.46e-05	4.91e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK1—multiple sclerosis	1.43e-05	4.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—multiple sclerosis	1.38e-05	4.63e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—multiple sclerosis	1.37e-05	4.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—multiple sclerosis	1.35e-05	4.56e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—multiple sclerosis	1.35e-05	4.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK1—multiple sclerosis	1.35e-05	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—multiple sclerosis	1.26e-05	4.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—multiple sclerosis	1.26e-05	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK1—multiple sclerosis	1.23e-05	4.14e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—multiple sclerosis	1.21e-05	4.06e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—multiple sclerosis	1.13e-05	3.81e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—multiple sclerosis	1.1e-05	3.7e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—multiple sclerosis	1.03e-05	3.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—multiple sclerosis	9.46e-06	3.18e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—multiple sclerosis	9.11e-06	3.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—multiple sclerosis	7.82e-06	2.63e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—multiple sclerosis	7.13e-06	2.4e-05	CbGpPWpGaD
